Skip to main content
. 2010 Nov;51(11):3342–3349. doi: 10.1194/jlr.M010009

TABLE 3.

Association of SNPs located in the PCSK9 locus with early-onset MI, and LDL and total cholesterol levels

Position on chr 1 (bp) Minor Allele Minor Allele Frequency (%)
MI
LDL Cholesterol
Total Cholesterol
SNP Cases Controls P OR (95% CI) P OR (95% CI) P OR (95% CI)
rs2479394 55,258,652 G 31.1 30.4 0.518 1.04 (0.93–1.16) 0.222 1.07 (0.96–1.19) 0.862 1.01 (0.92–1.11)
rs2479393 55,260,957 A 30.0 28.9 0.362 1.05 (0.94–1.18) 0.154 1.08 (0.97–1.2) 0.721 1.02 (0.92–1.12)
rs2479417 55,268,332 T 38.0 36.7 0.227 1.07 (0.96–1.19) 0.345 1.05 (0.95–1.16) 0.488 1.03 (0.94–1.13)
rs2495497 55,268,583 T 13.6 12.8 0.646 1.04 (0.89–1.20) 0.332 1.07 (0.93–1.24) 0.325 1.07 (0.94–1.21)
rs11206510 55,268,627 C 18.9 20.6 0.144 0.91 (0.80–1.03) 1.89E-03 0.82 (0.73–0.93) 8.12E-05 0.80 (0.72–0.89)
rs2094470 55,269,890 C 6.5 5.9 0.182 1.15 (0.93–1.42) 0.680 0.96 (0.79–1.17) 0.603 1.05 (0.87–1.26)
rs7523242 55,271,537 T 22.4 21.0 0.384 1.06 (0.93–1.19) 0.305 1.06 (0.94–1.20) 0.256 1.06 (0.96–1.19)
rs2495488 55,272,794 T 5.6 5.5 0.653 1.05 (0.84–1.31) 0.908 0.99 (0.80–1.22) 0.694 1.04 (0.86–1.26)
rs2182833 55,273,017 G 22.8 21.7 0.457 1.05 (0.93–1.18) 0.465 1.04 (0.93–1.18) 0.310 1.06 (0.95–1.18)
rs10788994 55,273,564 T 22.8 21.5 0.401 1.05 (0.93–1.19) 0.334 1.06 (0.94–1.19) 0.225 1.07 (0.96–1.19)
rs2149041 55,274,725 G 22.3 21.0 0.406 1.06 (0.93–1.20) 0.205 1.08 (0.96–1.22) 0.192 1.08 (0.96–1.20)
rs2479409 55,277,238 G 34.2 33.3 0.442 1.04 (0.94–1.16) 0.133 1.08 (0.98–1.20) 0.025 1.11 (1.01–1.22)
rs10888897 55,277,985 T 42.0 43.5 0.256 0.94 (0.85–1.04) 0.974 1.00 (0.91–1.11) 0.954 1.00 (0.92–1.10)
rs2479412 55,285,649 G 4.8 4.7 0.903 0.99 (0.78–1.25) 0.404 1.10 (0.88–1.37) 0.155 1.16 (0.94–1.43)
rs2495477 55,286,661 G 39.4 42.2 0.105 0.92 (0.83–1.02) 0.446 0.96 (0.87–1.07) 0.121 0.93 (0.85–1.02)
rs2479413 55,291,055 T 31.8 33.8 0.180 0.93 (0.83–1.03) 0.759 0.98 (0.88–1.09) 0.366 0.96 (0.87–1.05)
rs7552841 55,291,270 T 40.2 39.9 0.792 0.99 (0.89–1.09) 0.971 1.00 (0.90–1.11) 0.456 1.04 (0.94–1.13)
rs693668 55,291,340 G 35.6 37.8 0.273 0.94 (0.85–1.05) 0.404 0.96 (0.86–1.06) 0.203 0.94 (0.86–1.03)
rs568052 55,293,697 G 29.2 30.0 0.569 0.97 (0.86–1.08) 0.377 0.95 (0.85–1.06) 0.174 0.93 (0.84–1.03)
rs631220 55,297,430 A 15.8 16.9 0.397 0.94 (0.82–1.08) 0.399 0.94 (0.82–1.08) 0.158 0.91 (0.81–1.04)
rs505151 55,300,067 G 3.8 3.2 0.390 1.13 (0.85–1.50) 0.166 1.20 (0.93–1.55) 0.098 1.22 (0.96–1.54)
rs13312 55,301,775 G 17.7 19.1 0.403 0.95 (0.83–1.08) 0.721 0.98 (0.86–1.11) 0.350 0.95 (0.84–1.06)
rs593398 55,305,330 C 3.6 3.4 0.676 1.06 (0.81–1.39) 0.182 1.20 (0.92–1.58) 0.474 1.09 (0.86–1.40)

P-values are presented as noncorrected for multiple testing. Significant results are indicated in bold.